Brief: Ryvu Therapeutics Says Its Project Recommended For Funding By Medical Research Agency
07/02/2025 06:51
Feb 7 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* ADCRAFT PROJECT RECOMMENDED FOR FUNDING BY MEDICAL
RESEARCH
AGENCY
* PROJECT TOTAL NET VALUE IS PLN 13.2 MILLION
* RECOMMENDED FUNDING AMOUNT IS PLN 9.88 MILLION
Source text: urn:newsml:reuters.com:*:nEMC2dY5a
Further company coverage: RVU.WA
(Reporting by Gdańsk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project